Xcelience talks about "molecular responsibility" in describing itself on its website. Nice gave it a 78% CP score, just three points behind Therapure. But Xcelience has a 50% CA rating compared with Therapure's 41%, providing some balance.
Xcelience has been busy: last month it expanded its clinical trial supplies manufacturing and packaging capabilities. In August, it teamed with Bend Research to speed drug product intermediates to early-phase trials. The company also expanded its Tampa, FL, headquarters, to accommodate the doubling of employees that it plans over the next three years.
The CMO provides formulation development and manufacturing solutions, and specializes in early-phase small-molecule development.
Pre-formulation, analytical method development and validation, GMP manufacturing, stability program management and its Chemistry Playbook, an aid for developing CMC solutions, are additional offerings.